Company Filing History:
Years Active: 2001-2003
Title: The Innovations of Nancy E. Pfeiffer
Introduction
Nancy E. Pfeiffer is a notable inventor based in Seward, NE (US). She has made significant contributions to the field of veterinary medicine, particularly in the diagnosis and prevention of diseases affecting felines. With a total of 2 patents, her work has had a meaningful impact on the health and well-being of cats.
Latest Patents
Pfeiffer's latest patents include innovations related to recombinant feline coronavirus S proteins. The first patent focuses on polypeptides and proteins that are useful in diagnosing and preventing diseases caused by feline infectious peritonitis virus (FIPV) and feline enteric coronavirus (FECV). The second patent provides polynucleotide molecules encoding portions of the S protein from FIPV, as well as the entire S protein or portions thereof from FECV. These polynucleotide molecules serve as valuable diagnostic reagents.
Career Highlights
Nancy E. Pfeiffer is currently associated with Pfizer Corporation, where she continues to advance her research and innovations. Her work has been instrumental in developing solutions that address critical health issues in cats, showcasing her dedication to veterinary science.
Collaborations
Throughout her career, Pfeiffer has collaborated with esteemed colleagues, including Timothy J. Miller and Albert Paul Reed. These partnerships have fostered a collaborative environment that enhances the quality and reach of her research.
Conclusion
Nancy E. Pfeiffer's contributions to veterinary medicine through her patents and collaborations highlight her commitment to improving feline health. Her innovative work continues to pave the way for advancements in the diagnosis and treatment of feline diseases.